Khurana, A., & Shafer, D. A. (2019). MDM2 antagonists as a novel treatment option for acute myeloid leukemia: Perspectives on the therapeutic potential of idasanutlin (RG7388). Onco Targets Ther.
Stile di citazione ChicagoKhurana, Arushi, e Danielle A. Shafer. "MDM2 Antagonists As a Novel Treatment Option for Acute Myeloid Leukemia: Perspectives On the Therapeutic Potential of Idasanutlin (RG7388)." Onco Targets Ther 2019.
Citazione MLAKhurana, Arushi, e Danielle A. Shafer. "MDM2 Antagonists As a Novel Treatment Option for Acute Myeloid Leukemia: Perspectives On the Therapeutic Potential of Idasanutlin (RG7388)." Onco Targets Ther 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.